Corosolic Acid Inhibits Secretory Phospholipase A₂IIa as an Anti-Inflammatory Function and Exhibits Anti-Tumor Activity in Ehrlich Ascites Carcinoma Bearing Mice

References

• Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121. doi:10.4103/aam.aam_56_18
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15(2):425–430. doi:10.1158/1078-0432.CCR-08-0149
   PubMed Web of Science ®Google Scholar
• Dranoff G. Immune recognition and tumor protection. Curr Opin Immunol. 2002;2(14):161–164. doi:10.1016/S0952-7915(02)00315-1
   Web of Science ®Google Scholar
• Pardoll DM. Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol. 2002;2(4):227–238. doi:10.1038/nri774
   PubMed Web of Science ®Google Scholar
• Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol. 1983;24(1):83–87. doi:10.1002/jso.2930240119
   PubMed Web of Science ®Google Scholar
• Harris RE, Beebe-Donk J, Doss H, Doss DB. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep. 2005;13(4):559–583.
   PubMed Web of Science ®Google Scholar
• Rayburn ER, Ezell SJ, Zhang R. Anti-inflammatory agents for cancer therapy. Mol Cell Pharmacol. 2009;1(1):29. doi:10.4255/mcpharmacol.09.05
   PubMedGoogle Scholar
• Todoric J, Antonucci L, Karin M. Targeting inflammation in cancer prevention and therapy. Cancer Prev Res. 2016;9(12):895–905. doi:10.1158/1940-6207.CAPR-16-0209
   PubMed Web of Science ®Google Scholar
• Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem. 1990;265(29):17381–17384. doi:10.1016/S0021-9258(18)38167-5
   PubMed Web of Science ®Google Scholar
• Bowton DL, Seeds MC, Fasano MB, Goldsmith B, Bass DA. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med. 1997;155(2):421–425.
   PubMed Web of Science ®Google Scholar
• Menschikowski M, Hagelgans A, Siegert G. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat. 2006;79(1–2):1–33.
   PubMed Web of Science ®Google Scholar
• Scott KF, Sajinovic M, Hein J, et al. Emerging roles for phospholipase A2 enzymes in cancer. Biochimie. 2010;92(6):601–610. doi:10.1016/j.biochi.2010.03.019
   PubMed Web of Science ®Google Scholar
• Meyer AM, Dwyer-Nield LD, Hurteau GJ, et al. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A 2. Carcinogenesis. 2004;25(8):1517–1524. doi:10.1093/carcin/bgh150
   PubMed Web of Science ®Google Scholar
• Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181–193. doi:10.1038/nrc2809
   PubMed Web of Science ®Google Scholar
• Dong Z, Liu Y, Scott KF, et al. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis. 2010;31(11):1948–1955. doi:10.1093/carcin/bgq188
   PubMed Web of Science ®Google Scholar
• Hatmi M, Samama MM, Elalamy I. Prevention of thrombosis and vascular inflammation: importance of combined cyclooxygenase and 5-lipoxygenase inhibitors. J Mal Vasc. 2006;31(1):4–9. doi:10.1016/S0398-0499(06)76511-8
   PubMedGoogle Scholar
• Nasir NN, Sekar M, Fuloria S, et al. Kirenol: a potential natural lead molecule for a new drug design, development, and therapy for inflammation. Molecules. 2022;27(3):734. doi:10.3390/molecules27030734
   PubMed Web of Science ®Google Scholar
• Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;1(180):114147. doi:10.1016/j.bcp.2020.114147
   Web of Science ®Google Scholar
• Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest. 2001;107(12):1491–1495. doi:10.1172/JCI13271
   PubMed Web of Science ®Google Scholar
• Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem. 2008;77(1):495–520. doi:10.1146/annurev.biochem.76.062405.154007
   PubMed Web of Science ®Google Scholar
• Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther. 2009;23(1):49–59. doi:10.1007/s10557-008-6132-9
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Kastelein JJ, Schwartz GG, et al. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the Vista-16 randomized clinical trial. JAMA. 2014;311(3):252–262. doi:10.1001/jama.2013.282836
   PubMed Web of Science ®Google Scholar
• Zeiher BG, Steingrub J, Laterre PF, Dmitrienko A, Fukiishi Y, Abraham E; EZZI Study Group. LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med. 2005;33(8):1741–1748. doi:10.1097/01.CCM.0000171540.54520.69
   PubMed Web of Science ®Google Scholar
• Garcia-Pastor P, Randazzo A, Gomez-Paloma L, Alcaraz MJ, Paya M. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation. J Pharmacol Exp Ther. 1999;289(1):166–172.
   PubMed Web of Science ®Google Scholar
• Gohil KJ, Patel JA, Gajjar AK. Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian J Pharm Sci. 2010;72(5):546. doi:10.4103/0250-474X.78519
   PubMed Web of Science ®Google Scholar
• Miura T, Ueda N, Yamada K, et al. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice. Biol Pharm Bull. 2006;29(3):585–587. doi:10.1248/bpb.29.585
   PubMed Web of Science ®Google Scholar
• Banno N, Akihisa T, Tokuda H, et al. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Biosci Biotechnol Biochem. 2004;68(1):85–90. doi:10.1271/bbb.68.85
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M. Corosolic acid prevents oxidative stress, inflammation, and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci. 2006;79(26):2474–2479. doi:10.1016/j.lfs.2006.08.007
   PubMed Web of Science ®Google Scholar
• Zong W, Zhao G. Corosolic acid isolation from the leaves of Eriobotrya japonica showing the effects on carbohydrate metabolism and differentiation of 3T3-L1 adipocytes. Asia Pac J Clin Nutr. 2007;16(Suppl 1):346–352.
   PubMedGoogle Scholar
• Ma B, Zhang H, Wang Y, et al. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J Exp Clin Cancer Res. 2018;37(1):1–6. doi:10.1186/s13046-018-0889-x
   PubMed Web of Science ®Google Scholar
• Dharmappa KK, Kumar RV, Nataraju A, Mohamed R, Shivaprasad HV, Vishwanath BS. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med. 2009;75(03):211–215. doi:10.1055/s-0028-1088374
   PubMed Web of Science ®Google Scholar
• Niu G, Sun L, Pei Y, et al. Oleanolic acid inhibits colorectal cancer angiogenesis by blocking the VEGFR2 signaling pathway. Anticancer Agents Med Chem. 2018;18(4):583–590. doi:10.2174/1871520617666171020124916
   PubMed Web of Science ®Google Scholar
• Kasturi S, Gowda TV. Purification and characterization of a major phospholipase A2 from Russell’s viper (Vipera russelli) venom. Toxicon. 1989;27(2):229–237. doi:10.1016/0041-0101(89)90136-0
   PubMed Web of Science ®Google Scholar
• Laemmli UK; Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. nature. 1970;227(5259):680–685. doi:10.1038/227680a0
   PubMed Web of Science ®Google Scholar
• Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363–7. doi:10.1093/nar/gky473
   PubMed Web of Science ®Google Scholar
• Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler PB. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science. 1991;254(5034):1007–1010. doi:10.1126/science.1948070
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Shastri SL, Krishna V, Ravi Kumar S, Pradeepa K. Phytochemical analysis, antibacterial property and molecular docking studies of Mammea suriga Kosterm. World J Pharm Res. 2016;4:331–340.
   Google Scholar
• Jinadatta P, Rajshekarappa S, Rao KS, Subbaiah SG, Shastri S. In silico, in vitro: antioxidant and antihepatotoxic activity of gnetol from Gnetum ula Brongn. BioImpacts. 2019;9(4):239. doi:10.15171/bi.2019.29
   PubMed Web of Science ®Google Scholar
• Shastri SL, Krishna V. Jayabaskaran C.In Silico Analysis of ADME-T Properties of Amentoflavone. Bioinform Proteom Opn Acc J. 2017;1(3):000118.
   Google Scholar
• Patriarca P, Beckerdite S, Pettis P, Elsbach P. Phospholipid metabolism by phagocytic cells: VII The degradation and utilization of phospholipids of various microbial species by rabbit granulocytes. Biochim Biophys Acta. 1972;280(1):45–56. doi:10.1016/0005-2760(72)90211-1
   PubMed Web of Science ®Google Scholar
• Pastwińska J, Karaś K, Sałkowska A, et al. Identification of corosolic and oleanolic acids as molecules antagonizing the human RORγT nuclear receptor using the calculated fingerprints of the molecular similarity. Int J Mol Sci. 2022;23(3):1906. doi:10.3390/ijms23031906
   PubMed Web of Science ®Google Scholar
• Prigent-Dachary J, Boffa MC, Boisseau MR, Dufourcq J. Snake venom phospholipases A2 A fluorescence study of their binding to phospholipid vesicles correlation with their anticoagulant activities. J Biol Chem. 1980;255(16):7734–7739.
   PubMed Web of Science ®Google Scholar
• Boman HG, Kaletta U. Chromatography of rattlesnake venom A separation of three phosphodiesterases. Biochim Biophys Acta. 1957;Jan(24):619–631. doi:10.1016/0006-3002(57)90256-1
   Web of Science ®Google Scholar
• Yamakawa M, Nozaki M, Hokama Z. Fractionation of sakishimahabu (Trimeresurus elegans) venom and lethal, hemorrhagic and edema-forming activities of the fractions. Animal Plant Microbial Toxins. 1976;1:97–109.
   Google Scholar
• Vishwanath BS, Gowda TV. Interaction of aristolochic acid with Vipera russelli phospholipase A2: its effect on enzymatic and pathological activities. Toxicon. 1987;25(9):929–937. doi:10.1016/0041-0101(87)90155-3
   PubMed Web of Science ®Google Scholar
• Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48(3):589–601.
   PubMed Web of Science ®Google Scholar
• BD Biosciences . Product datasheet - FITC rabbit anti- active caspase-3 IgG Antibody - BD biosciences, catalogue no. 559341. Available from: https://www.bdbiosciences.com/content/dam/bdb/products/global/reagents/flow-cytometry-reagents/research-reagents/single-color-antibodies-ruo/559341_base/pdf/559341.pdf
   Google Scholar
• Dai C, Krantz SB. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. J Am Soc Hematol. 1999;93(10):3309–3316.
   Google Scholar
• Amidzadeh Z, Behbahani AB, Erfani N, et al. Assessment of different permeabilization methods of minimizing damage to the adherent cells for detection of intracellular RNA by flow cytometry. Avicenna J Med Biotechnol. 2014;6(1):38.
   PubMedGoogle Scholar
• Raihan M, Tareq SM, Brishti A, Alam M, Haque A, Ali M. Evaluation of antitumor activity of leea indica (Burm. f.) Merr. extract against Ehrlich Ascites Carcinoma (EAC) Bearing Mice. Am J Biomed Sci. 2012;4:143–152.
   Google Scholar
• BD Biosciences. BD Biosciences PE mouse anti-human IL-6 (Technical Data Sheet, Cat No: 340527). Available from: https://www.bdbiosciences.com/content/dam/bdb/products/global/reagents/flow-cytometry-reagents/clinical-discovery-research/single-color-antibodies-ruo-gmp/340527_base/pdf/23-3468.pdf
   Google Scholar
• Mohamed R, Dharmappa KK, Tarannum S, et al. Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. Mol Cell Biochem. 2010;345(1):69–76. doi:10.1007/s11010-010-0561-z
   PubMed Web of Science ®Google Scholar
• Mohamed R, Shivaprasad H, Jameel N, Shekar M, Vishwanath B. Neutralization of local toxicity induced by Vipera russelli phospholipase A2 by lipophilic derivative of ascorbic acid. Curr Top Med Chem. 2011;11(20):2531–2539. doi:10.2174/156802611797633429
   PubMed Web of Science ®Google Scholar
• Dileep KV, Remya C, Cerezo J, Fassihi A, Pérez-Sánchez H, Sadasivan C. Comparative studies on the inhibitory activities of selected benzoic acid derivatives against secretory phospholipase A 2, a key enzyme involved in the inflammatory pathway. Mol Biosyst. 2015;11(7):1973–1979. doi:10.1039/C5MB00073D
   PubMedGoogle Scholar
• Gnanaraj C, Sekar M, Fuloria S, et al. In silico molecular docking analysis of karanjin against alzheimer’s and parkinson’s diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules. 2022;27(9):2834. doi:10.3390/molecules27092834
   PubMed Web of Science ®Google Scholar
• Toyama DO, Ferreira MJ, Romoff P, Fávero OA, Gaeta HH, Toyama MH. Effect of chlorogenic acid (5-Caffeoylquinic Acid) Isolated from baccharis oxyodonta on the structure and pharmacological activities of secretory phospholipase A2 from Crotalus durissus terrificus. Biomed Res Int. 2014;2014:1–10. doi:10.1155/2014/726585
   Web of Science ®Google Scholar
• Bomalaski JS, Lawton P, Browning JL. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol. 1991;146(11):3904–3910.
   PubMed Web of Science ®Google Scholar
• Weichman BM, Berkenkopf JW, Marshall LA. Phospholipase A2-induced pleural inflammation in rats. Int J Tissue React. 1989;11(3):129–136.
   PubMedGoogle Scholar
• Fawzy AA, Vishwanath BS, Franson RC. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mech Action Agents Action. 1988;25(3):394–400. doi:10.1007/BF01965048
   PubMedGoogle Scholar
• Vecchi L, Araújo TG, Azevedo FV, et al. Phospholipase A2 Drives tumorigenesis and cancer aggressiveness through its interaction with annexin A1. Cells. 2021;10(6):1472. doi:10.3390/cells10061472
   PubMed Web of Science ®Google Scholar
• Javed Z, Khan K, Herrera-Bravo J, et al. Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int. 2021;21(1):1–2. doi:10.1186/s12935-021-02091-8
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim HS, Song YS. Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med. 2012;2(2):96–104. doi:10.1016/S2225-4110(16)30082-7
   PubMedGoogle Scholar
• Kim JH, Kim YH, Song GY, et al. Ursolic acid and its natural derivative corosolic acid suppress the proliferation of APC-mutated colon cancer cells through promotion of β-catenin degradation. Food Chem. 2014;1(67):87–95. doi:10.1016/j.fct.2014.02.019
   Web of Science ®Google Scholar
• Horlad H, Fujiwara Y, Takemura K, et al. Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid‐derived suppressor cells. Mol Nutr Food Res. 2013;57(6):1046–1054. doi:10.1002/mnfr.201200610
   PubMed Web of Science ®Google Scholar
• Yoo KH, Park J-H, Lee DY, Hwang-Bo J, Baek NI, Chung IS. Corosolic acid exhibits Anti-angiogenic and Anti-lymphangiogenic effects on in vitro endothelial cells and on an in vivo CT-26 colon carcinoma animal model. Phytotherapy Res. 2015;29(5):714–723. doi:10.1002/ptr.5306
   PubMed Web of Science ®Google Scholar
• Qian XP, Zhang XH, Sun LN, et al. Corosolic acid and its structural analogs: a systematic review of their biological activities and underlying mechanism of action. Phytomedicine. 2021;1(91):153696. doi:10.1016/j.phymed.2021.153696
   Web of Science ®Google Scholar
• Lu Y, Chen GQ. Effector caspases and leukemia. Int J Cell Biol. 2011;2011:1–8. doi:10.1155/2011/738301
   Google Scholar
• Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin. 2011;30(1):1–4. doi:10.1186/1756-9966-30-87
   PubMed Web of Science ®Google Scholar
• Tazuke Y, Drongowski RA, Teitelbaum DH, Coran AG. Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model. Pediatr Surg Int. 2003;19(5):321–325. doi:10.1007/s00383-003-1003-8
   PubMed Web of Science ®Google Scholar
• Bertsch T, Banks RE, Forbes MA, et al. Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer. Ann Clin Biochem. 1996;33(6):565–567. doi:10.1177/000456329603300615
   PubMed Web of Science ®Google Scholar
• Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol. 1992;62(1):S60–5. doi:10.1016/0090-1229(92)90042-M
   PubMedGoogle Scholar
• Vainer N, Dehlendorff C, Johansen JS. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget. 2018;9(51):29820. doi:10.18632/oncotarget.25661
   PubMedGoogle Scholar